Yanhong Guo
University of Michigan–Ann Arbor(US)Michigan United(US)Wuhan Business University(CN)Michigan Medicine(US)Ann Arbor VA Medical Center(US)China XD Group (China)(CN)First Affiliated Hospital of Zhengzhou University(CN)
Publications by Year
Research Areas
Renal Diseases and Glomerulopathies, Adipose Tissue and Metabolism, X-ray Diffraction in Crystallography, Cardiovascular Disease and Adiposity, Heart Failure Treatment and Management
Most-Cited Works
- → Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk(2014)310 cited
- → Endothelial TFEB (Transcription Factor EB) Positively Regulates Postischemic Angiogenesis(2018)123 cited
- → Perhexiline activates KLF14 and reduces atherosclerosis by modulating ApoA-I production(2015)113 cited
- → Brown Adipocyte-Specific PPARγ (Peroxisome Proliferator-Activated Receptor γ) Deletion Impairs Perivascular Adipose Tissue Development and Enhances Atherosclerosis in Mice(2018)83 cited
- → Diverse triterpene skeletons are derived from the expansion and divergent evolution of 2,3-oxidosqualene cyclases in plants(2021)63 cited
- → Nitro-fatty acids protect against steatosis and fibrosis during development of nonalcoholic fatty liver disease in mice(2019)62 cited